Investors knock $1b off F&P Healthcare valuation

Investors knock $1b off F&P Healthcare valuation
Dan Brunskill
New Zealand's main share index slumped as investors reacted poorly to Fisher & Paykel Healthcare’s full-year result which failed to meet the high expectations priced into the stock. The S&P/NZX 50 Index fell 104.1 points, or 0.8%, to 12,243.34. Within the index, 27 stocks fell, 16 rose and 7 were unchanged. The index has fallen more than 8% this year. F&P Healthcare has been doing extraordinarily well during the pandemic as the exporter supplies hospitals around the world with equipment needed to treat covid-19.T...

More Markets

NZ sharemarket up 0.4% after a2 Milk surge
Markets Market Close

NZ sharemarket up 0.4% after a2 Milk surge

The S&P/NZX 50 Index closed at 12,266.25, gaining 57.2 points or 0.47%.

Goldman Sachs downgrades Fletcher Building to sell
Markets

Goldman Sachs downgrades Fletcher Building to sell

Goldman Sach analysts have a 12-month target price of A$2.85 ($3.14).

Rayonier exits NZ with $1.2b forestry sale
Primary Sector

Rayonier exits NZ with $1.2b forestry sale

An investment firm bought the stake, which included 116,145 hectares of forestry.

NZME board told 'compromise or be rolled'
Markets

NZME board told 'compromise or be rolled'

Minority shareholders are falling in behind billionaire Jim Grenon's board coup.